@inproceedings{f7b65bb8b95646aeabf797059b439d45,
title = "Minimizing the intra- pathologist disagreement for tumor bud detection on H&E images using weakly supervised learning",
abstract = "Tumor budding (TB) is defined as a cluster of one to four tumor cells at the tumor invasive front. Though promising as a prognostic factor for colorectal cancer, its routine clinical use is hampered by high inter- and intra- observer disagreement on routine H&E staining. Pan-cytokeratin immunohistochemical staining increases agreement but is costly, non-routine, and may yield false tumor buds (false positives). This makes the development of automatic algorithms to identify TB difficult. Therefore, we propose a weakly-supervised method that does not require strictly accurate tissue-level annotations and is resilient to false positives. Our database consists of 29 H&E whole slide images. TB and non-tumor ROIs were generated by cropping 512x512 regions around annotated tumor buds and within annotated non-tumor regions, respectively. Attention-based multiple instance learning was applied to identify ROIs containing tumor buds. This resulted in a precision of 0.9477 ± 0.0516, recall of 0.9131 ± 0.0568, and AUC of 0.9482 ± 0.0679 on an external dataset. These results provide preliminary evidence for the feasibility of our method to identify tumor buds accurately.",
keywords = "colorectal cancer, deep learning, tumor budding, weak supervision",
author = "Tavolara, {Thomas E.} and Wei Chen and Frankel, {Wendy L.} and Gurcan, {Metin Nafi} and Niazi, {M. Khalid Khan}",
note = "Funding Information: The project described was supported in part by U01 CA220401 (PIs: Gurcan, Cooper, Flowers), R01 CA235673 (PI: Puduvalli) from the National Cancer Institute, UL1 TR001420 (PI: McClain) from National Center for Advancing Translational Sciences, and the Alliance Clinical Trials in Oncology GR125886 (PIs: Frankel and Niazi). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute, National Heart Lung and Blood Institute, or the National Institutes of Health. Publisher Copyright: {\textcopyright} 2023 SPIE.; Medical Imaging 2023: Digital and Computational Pathology ; Conference date: 19-02-2023 Through 23-02-2023",
year = "2023",
doi = "10.1117/12.2653887",
language = "English",
series = "Progress in Biomedical Optics and Imaging - Proceedings of SPIE",
publisher = "SPIE",
editor = "Tomaszewski, {John E.} and Ward, {Aaron D.}",
booktitle = "Medical Imaging 2023",
}